CLOVER BIOPHARMACEUTICALS LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 2197 for the last semiannual is 42.13 M HKD, and it's 14395.22% higher compared to the previous semiannual. The net income of H2 23 is -852.56 M HKD.